Hyperinflammation and Hyperferritinemia in Critically Ill Patients
Critical Illness · Sepsis · Hyperferritinemia · Hyperinflammatory Syndrome
What this study involves
The registry says this study is recruiting. Individual locations may have different availability.
- Study type
- Observational
- Phase
- Not applicable / not listed
- Age range
- 18 years - Not specified
- Sex eligible
- All sexes
- Healthy volunteers
- Not accepted
- Participants
- 1962 Estimated
These are starting points, not an eligibility decision. The research team must review the full requirements.
About the research
Analysing trajectory of critically ill patients with signs of hyperinflammation
Who may be able to participate?
The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.
Inclusion Criteria:
- critically ill patients
- admission between 01.01.2020 and 31.12.2024 (5yrs)
Exclusion Criteria:
- none
Study population
critically ill patients; mix-cases medical ICU population
Understand screeningTreatment, groups and participation
The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.
- Assignment
- Not reported
- Masking
- Not reported
critically ill patients
critically ill patients admitted to ICU between 01.01.2020 and 31.12.2024
What researchers are measuring
Outcome measures describe what is being studied. They are not proof that a treatment works.
Primary measures
hyperferritinemia
Time frame: 2025
trajectory of critically ill patients with significant hyperferritinemia and with regard to its dynamics; ferritin value cutt-off
Secondary measures
etiology and association of hyperferritinemia
Time frame: 2025
etiology and association of hyperferritinemia with infectioius a non-infectious diseases/conditions
mortality a morbidity
Time frame: 2025
mortality a morbidity of patients with significant hyperferritinemia
treatment strategy
Time frame: 2025
association of hyperferritinemia and treatment strategy
stratification
Time frame: 2025
patient stratification according to hyperferritinemia/hyperinflammation
Review the complete result tables and limitations in the official record.
Open official results ↗Research locations (1)
The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.
1 locations
Faculty of Medicine and Teaching Hospital, Charles UniversityPilsen, Czech Republic, CzechiaRecruiting
Study team and timeline
- Lead sponsor
- Charles University, Czech Republic
- Study start
- Oct 1, 2026 Actual
- Primary completion
- Dec 31, 2027 Estimated
- Study completion
- Jun 30, 2028 Estimated
- First posted
- Feb 11, 2025 Actual
- Last updated
- Nov 10, 2026 Actual
Official study contacts
Official study title
Hyperinflammation and Hyperferritinemia in Critically Ill Patients: a Retrospective Observational Single-center Analysis
Ask Wellness Clinical Research
Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.
Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.
Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026